Wilson pointed out that aerosol cannisters deliver less drug when nearing exhaustion which would lead to a decline in the response to the drug. Most likely the development of drug tolerance to beta, agonists involves more than one mechanism.
Subsensitivity of Beta Responses on Terbutaline Therapy
John W. Jenne, M.D.
e studied 19 stable patients with asthma and w b .
mc bronchitis who were taken off all oral sympathomimetic agents for two weeks. Patients were given 5.0 mg terbutaline orally as the initial beta challenge (To) and then were given terbutaline maintenance at 5.0 mg. tid with successive weekly challenges by terbutaline at one, two, and three weeks (TI, TI,, and T,,,) while on maintenance terbutaline and at one and two weeks off terbutaline (T,,,,, T,,,,,) . Theophylline compounds were used until 18 hours (slow-release) or 12 hours (plain aminophylline) before challenge and inhaled adrenergic aerosols until 4 hours before challenge if needed.
We found a 61 percent reduction in plasma cyclic AMP responses to terbutaline challenge after one week for maximum depression (it still might have been depressed further with longer terbutaline maintenance therapy) but bad partially returned to the original response at one week off terbutaline, and fully returned by two weeks off terbutaline. There was also significant tolerance in the blood sugar elevation and the drop in peripheral eminophils.
In Figure 2 we see the baseline vital capacity (VC), FEV,, diastolic blood pressure, specific airway resistance and velocity of flow at 50 percent of vital capacity (V,,). Also shown is the maximum response in these measurements with terbutaline challenge, as shown by the arrow. By T, (one week of terbutaline maintenance) we see a significant 7 percent drop in peak FEV, and a 21 percent drop in V, . response to challenge. In the next slide using fewer patients there is shown a 15 percent and 32 percent reduction in these responses respectively at the combined second and third week (T ,,.,,, ). Responses tended to return to normal off the drug. The drop in diastolic pressures lessened significantly but other responses showed insisifi cant changes.
Although this protocol does bring out tolerance development of bronchial beta responses, I would like to emphasize that in the mventional use of these drugs on a divided dose schedule, where baseline values improve, the effect of this tolerance is imperceptible with the peak response being maintained. These data in no way are arguments against their use. It is conceivable, however, that during a severe attack with associated overuse of an adrenergic inhaler, or following the abrupt withdrawal of adrenergic agents, this tolerance might become clinically important.
A Three Month Study of the
e have studied the efficacy and safety of single and w repehtlve . . aerosolized doses of fenoterol, a sympathomimetic bronchodilator chemically related to metaproterenol, in comparison with isoproterenol. Fortyfive ambulatory patients were selected with relatively stable mild-to-moderate airways obstruction that was reversible. Reversibility was demonstrated by an improvement of FEV, to at least 20 percent within 30 minutes following inhalations of 0.15 mg of isoproterenol sulfate from a metered dose inhaler on two challenge days separated by a two-week interval. Patients were randomly assigned by order of admission to the study to receive repetitive doses of either fenoterol M isoproterenol for a three-month period. The response of patients to single test doses of their assigned treatment was determined on days 1, 45 and 90. Thuty-one patients (17 with fenoterol and 14 with isoproterenol) completed the study.
Pulmonary function variables were measured on each test day at baseline, and 1 minute, 20 minutes, 1 , 2 , 3,4, 5, 6 and 8 hours after test dose. Forced expiratory volume in 1 second (FEV,) was measured using a CPI 220 spirometer with a pulmo-norm digitizer model 580. Thoracic gas volume and h a y resistance were determined by use of a whole body plethysmograph (Warren E. Collins, lnc., Braintree, Mass.) and specific airway conductance ( G a w / v~) was calculated. Respiratory loops were displayed on a storage oscilloscope and recorded for later analysis using videotape equipment with a specially m d e d monitor. Values used were the average of duplicate determinations.
The results of the pulmonary function studies are shown in Tables 1 and 2 . Differences with isoproterenol were generally in favor of fenoterol. Those differences attaining statistical s i~c a n c e are indicated. 
